LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 50

Suchoptionen

  1. Artikel ; Online: Editorial: combined cancer therapy.

    Pavelic, Jasminka

    Current pharmaceutical design

    2014  Band 20, Heft 42, Seite(n) 6511–6512

    Mesh-Begriff(e) Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Combined Modality Therapy ; Humans ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Neoplasms/pathology
    Sprache Englisch
    Erscheinungsdatum 2014-09-01
    Erscheinungsland United Arab Emirates
    Dokumenttyp Editorial ; Introductory Journal Article
    ZDB-ID 1304236-1
    ISSN 1873-4286 ; 1381-6128
    ISSN (online) 1873-4286
    ISSN 1381-6128
    DOI 10.2174/1381612820666140826154834
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: ESTIMATION OF AIRBORNE 106RU ACTIVITY CONCENTRATION FROM TOTAL BETA ACTIVITY OF PM10 PARTICLE FRACTIONS.

    Suric Mihic, Marija / Beslic, Ivan / Davila, Silvije / Marovic, Gordana / Pavelić, Luka / Sencar, Jasminka

    Radiation protection dosimetry

    2020  Band 189, Heft 4, Seite(n) 497–504

    Abstract: Airborne radioruthenium, as a result of an accidental release, presents a risk for occupational and public exposure. In fall 2017, a detection of 106Ru was reported by the European atmospheric radioactive contamination monitoring networks. We ... ...

    Abstract Airborne radioruthenium, as a result of an accidental release, presents a risk for occupational and public exposure. In fall 2017, a detection of 106Ru was reported by the European atmospheric radioactive contamination monitoring networks. We investigated the daily specific total beta activity of PM10 particle fractions samples. The presented method enables indirect determination of airborne 106Ru activity concentration from total beta activity, in case 106Ru was confirmed as single excess radiological pollutant. This allows for daily measurements and time-resolved 106Ru activity concentration data. We estimated the indicative committed effective dose due to 106Ru inhalation for the Croatian population during the exposure period. Although the estimated dose value of ~169.7 nSv, for ~6-d duration of ruthenium air pollution, was very low, it was ~40 times higher than the value for Hinh from inhalation of other radionuclides (90Sr + 137Cs + 40K + 7Be).
    Mesh-Begriff(e) Beryllium ; Cesium Radioisotopes ; Radioisotopes ; Ruthenium Radioisotopes/analysis ; Strontium Radioisotopes
    Chemische Substanzen Beryllium-7 ; Cesium Radioisotopes ; Radioisotopes ; Ruthenium Radioisotopes ; Ruthenium-106 ; Strontium Radioisotopes ; Cesium-137 (4T2E65IAR7) ; Strontium-90 (5TZZ77Z4ER) ; Beryllium (OW5102UV6N)
    Sprache Englisch
    Erscheinungsdatum 2020-08-24
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 225912-6
    ISSN 1742-3406 ; 0144-8420
    ISSN (online) 1742-3406
    ISSN 0144-8420
    DOI 10.1093/rpd/ncaa067
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Poly(I:C) treatment influences the expression of calreticulin and profilin-1 in a human HNSCC cell line: a proteomic study.

    Matijević, Tanja / Pavelić, Jasminka

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

    2012  Band 33, Heft 4, Seite(n) 1201–1208

    Abstract: Polyinosinic:polycytidylic acid (poly (I:C)) has been formerly known to be an interferon inducer but the mechanism of its action was not revealed until the discovery of Toll-like receptors (TLRs). TLRs are members of transmembrane proteins that recognize ...

    Abstract Polyinosinic:polycytidylic acid (poly (I:C)) has been formerly known to be an interferon inducer but the mechanism of its action was not revealed until the discovery of Toll-like receptors (TLRs). TLRs are members of transmembrane proteins that recognize conserved molecular motifs of viral and bacterial origin and initiate innate immune response. Recent studies have shown that they are also expressed on tumor cells, but their role in these cells is still not clear. TLR3 recognizes double-stranded RNA (poly (I:C)) and is primarily involved in the defense against viruses. TLR3 ligand binding initiates the activation of transcription factors NF-κB, IRF family members, and AP-1, which can induce wide cascading effect on the cell and consequently activate many cellular processes. Since little is known about TLR3 target genes, we have used the proteomic approach to widen the current knowledge. In this study, we have discovered 15 differentially expressed proteins, mostly connected with protein metabolic processes. Furthermore, we have confirmed by Western blot that calreticulin and profilin-1, proteins which have been shown previously to be involved in processes connected with tumor progression, are differentially expressed after poly(I:C) treatment. By using TLR3 small interfering RNA, we showed that calreticulin expression might be TLR3 dependent, unlike profilin-1.
    Mesh-Begriff(e) Blotting, Western ; Calreticulin/metabolism ; Carcinoma, Squamous Cell/genetics ; Carcinoma, Squamous Cell/metabolism ; Carcinoma, Squamous Cell/pathology ; Cell Line, Tumor ; Down-Regulation/drug effects ; Electrophoresis, Gel, Two-Dimensional ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/metabolism ; Head and Neck Neoplasms/pathology ; Humans ; Mass Spectrometry ; Poly I-C/pharmacology ; Profilins/metabolism ; Proteome/metabolism ; Proteomics/methods ; RNA Interference ; Toll-Like Receptor 3/genetics ; Toll-Like Receptor 3/metabolism ; Up-Regulation/drug effects
    Chemische Substanzen Calreticulin ; Profilins ; Proteome ; Toll-Like Receptor 3 ; Poly I-C (O84C90HH2L)
    Sprache Englisch
    Erscheinungsdatum 2012-03-14
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605825-5
    ISSN 1423-0380 ; 0289-5447 ; 1010-4283
    ISSN (online) 1423-0380
    ISSN 0289-5447 ; 1010-4283
    DOI 10.1007/s13277-012-0366-7
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy.

    Mikulandra, Martina / Pavelic, Jasminka / Glavan, Tanja Matijevic

    Current medicinal chemistry

    2017  Band 24, Heft 19, Seite(n) 2011–2032

    Abstract: The immune system's first line of defense is innate immunity, largely based on a large family of pattern recognition receptors (PRRs) that recognize evolutionary conserved molecular motifs on pathogens called pathogen-associated molecular patterns (PAMPs) ...

    Abstract The immune system's first line of defense is innate immunity, largely based on a large family of pattern recognition receptors (PRRs) that recognize evolutionary conserved molecular motifs on pathogens called pathogen-associated molecular patterns (PAMPs). The most extensively studied family of PRRs is Toll-like receptors (TLRs), which can trigger various cellular pathways after ligand stimulation. Their role in cancer is still unresolved as there are many different studies showing contradictory results. TLRs have been associated with both tumor progression and immunosuppression as well as with apoptosis and immune system activation. With their ability to induce apoptotic response and activation of innate and adaptive immunity, TLRs are an interesting pharmacological target for the development of anticancer therapy. There are numerous studies including the clinical trials reviewed in this paper, indicating that TLR agonists, especially combined with other more conventional therapies such as chemotherapy and radiotherapy, are promising adjuvants or components of newly developed treatment regimens. Still, the increasing number of studies indicating protumorigenic consequences of TLR activation in various cancer types and recent reports of the existence of endogenous TLR ligands, forewarn that more studies on this topic are required before their inclusion into regular clinical practice.
    Mesh-Begriff(e) Adaptive Immunity/drug effects ; Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Clinical Trials as Topic ; Drug Discovery ; Humans ; Immunity, Innate/drug effects ; Molecular Targeted Therapy ; Neoplasms/drug therapy ; Neoplasms/immunology ; Signal Transduction/drug effects ; Toll-Like Receptors/agonists ; Toll-Like Receptors/immunology
    Chemische Substanzen Antineoplastic Agents ; Toll-Like Receptors
    Sprache Englisch
    Erscheinungsdatum 2017
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1319315-6
    ISSN 1875-533X ; 0929-8673
    ISSN (online) 1875-533X
    ISSN 0929-8673
    DOI 10.2174/0929867324666170320114359
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: The exploitation of Toll-like receptor 3 signaling in cancer therapy.

    Glavan, Tanja Matijevic / Pavelic, Jasminka

    Current pharmaceutical design

    2014  Band 20, Heft 42, Seite(n) 6555–6564

    Abstract: Toll-like receptors (TLRs) are a group of transmembrane receptors that recognize molecular motifs of pathogen origin and activate immune response. Although TLRs were first identified in immune system cells, recent studies show they can also be expressed ... ...

    Abstract Toll-like receptors (TLRs) are a group of transmembrane receptors that recognize molecular motifs of pathogen origin and activate immune response. Although TLRs were first identified in immune system cells, recent studies show they can also be expressed in tumor cells. TLR3 recognizes dsRNA or its synthetic ligand poly (I: C) and is responsible primarily for the defense against viral infections. Recent studies showed that TLR3 can trigger apoptosis in cancer cell. Furthermore, other dsRNA binding receptors (MDA5 and RIG-I), localized in cytoplasm, can also bind poly (I: C) and therefore contribute to this effect. With TLR3's capacity to induce apoptosis and activate the immune system at the same time, TLR3 ligands are an attractive therapeutic option for treatment of cancer. Novel therapies include combining poly (I: C) with other components such as chemotherapeutics, apoptosis enhancers, other TLR ligands and peptides activating the immune system. Slightly modified TLR3 agonists (Ampligen®, Hiltonol®, poly IC-LC) are already being used in clinical studies for cancer therapy as single agents or in combination with other drugs. On the other hand, latest studies forewarn that TLR3 activation can also have tumor promoting role so it is crucial to identify the terms by which TLR3 has pro-tumor/anti-tumor effect in order to safely implement TLR3 ligand based therapy into clinical trials.
    Mesh-Begriff(e) Humans ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Signal Transduction/drug effects ; Toll-Like Receptor 3/agonists ; Toll-Like Receptor 3/metabolism
    Chemische Substanzen Toll-Like Receptor 3
    Sprache Englisch
    Erscheinungsdatum 2014-09-01
    Erscheinungsland United Arab Emirates
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1304236-1
    ISSN 1873-4286 ; 1381-6128
    ISSN (online) 1873-4286
    ISSN 1381-6128
    DOI 10.2174/1381612820666140826153347
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Serum vitamin D levels in children with newly diagnosed and chronic immune thrombocytopenia.

    Čulić, Srđana / Markić, Joško / Petrović, Davor / Konjevoda, Paško / Pavelić, Jasminka

    Seminars in hematology

    2016  Band 53 Suppl 1, Seite(n) S67–9

    Abstract: The primary objective of the study was to assess the vitamin D (VD) status of patients suffering from ITP. Children from the case cohort (total 21) were recruited from chronic ITP patients (followed as outpatients) and newly diagnosed ITP (prospective ... ...

    Abstract The primary objective of the study was to assess the vitamin D (VD) status of patients suffering from ITP. Children from the case cohort (total 21) were recruited from chronic ITP patients (followed as outpatients) and newly diagnosed ITP (prospective study) patients. VD deficiency (values <75 nmol/L) was detected in 11 patients with newly diagnosed ITP, and seven patients with chronic ITP. Only three patients with newly diagnosed, and none with chronic ITP had normal VD values. Newly diagnosed ITP patients had statistically significantly higher values (P <.044) of VD than the patients with chronic type of ITP. Platelets values did not follow VD level. VD deficiency is very common in children with either newly diagnosed or chronic ITP form. Therefore there is a utility supplementing VD in these patients. To investigate the role of VD as an immune modulating drug for patients with ITP, a prospective randomized placebo-controlled trial needs to be performed.
    Mesh-Begriff(e) Adolescent ; Child ; Child, Preschool ; Chronic Disease ; Cohort Studies ; Female ; Humans ; Male ; Purpura, Thrombocytopenic, Idiopathic/blood ; Purpura, Thrombocytopenic, Idiopathic/immunology ; Vitamin D/blood
    Chemische Substanzen Vitamin D (1406-16-2)
    Sprache Englisch
    Erscheinungsdatum 2016-04-11
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 206923-4
    ISSN 1532-8686 ; 0037-1963
    ISSN (online) 1532-8686
    ISSN 0037-1963
    DOI 10.1053/j.seminhematol.2016.04.020
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: The dual role of TLR3 in metastatic cell line.

    Matijevic, Tanja / Pavelic, Jasminka

    Clinical & experimental metastasis

    2011  Band 28, Heft 7, Seite(n) 701–712

    Abstract: Toll-like receptors (TLRs) are members of transmembrane proteins that recognize conserved molecular motifs of viral and bacterial origin and initiate innate immune response. As the role of TLRs in tumors cells is still not clear, our aim was to ... ...

    Abstract Toll-like receptors (TLRs) are members of transmembrane proteins that recognize conserved molecular motifs of viral and bacterial origin and initiate innate immune response. As the role of TLRs in tumors cells is still not clear, our aim was to investigate the role of TLR3 in primary tumor and metastatic cells (SW480, SW620, FaDu and Detroit 562). We have reported here on the dual role of TLR3 in pharynx metastatic cell line (Detroit 562); on one hand TLR3 activation drove cells to apoptosis while on the other its stimulation contributed to tumor progression by altering the expression of tumor promoting genes (PLAUR, RORB) and enhancing the cell migration potential. In addition, we have shown TLR3 signaling pathway is functional in another metastatic cancer cell line (SW620) suggesting TLR3 might be important in the process of tumor metastasis. Since TLR3 agonists have been used in tumor therapy with the aim to activate immune system, scientific contribution of this work is drawing attention to the importance of further work on this topic, especially pro-tumor effect of TLR3, in order to avoid possible side-effects.
    Mesh-Begriff(e) Apoptosis ; Cell Line, Tumor ; Cell Movement ; Colonic Neoplasms/genetics ; Colonic Neoplasms/metabolism ; Colonic Neoplasms/pathology ; Disease Progression ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Metastasis/genetics ; Neoplasm Metastasis/pathology ; Pharyngeal Neoplasms/metabolism ; Pharyngeal Neoplasms/pathology ; Pharyngeal Neoplasms/secondary ; Signal Transduction ; Toll-Like Receptor 3/genetics ; Toll-Like Receptor 3/metabolism
    Chemische Substanzen Toll-Like Receptor 3
    Sprache Englisch
    Erscheinungsdatum 2011-07-07
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 604952-7
    ISSN 1573-7276 ; 0262-0898
    ISSN (online) 1573-7276
    ISSN 0262-0898
    DOI 10.1007/s10585-011-9402-z
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Antitumor activity from the combined application of poly(I:C) and chemotherapeutics in human metastatic pharyngeal cell lines.

    Matijević, Tanja / Kirinec, Gabriela / Pavelić, Jasminka

    Chemotherapy

    2011  Band 57, Heft 6, Seite(n) 460–467

    Abstract: Background: Toll-like receptor 3 (TLR3) activation in tumor cells induces apoptosis. We investigated the effect of TLR3 ligand (poly(I:C)) in combination with chemotherapeutics applied to human pharyngeal carcinoma cells as a possible antitumor therapy.! ...

    Abstract Background: Toll-like receptor 3 (TLR3) activation in tumor cells induces apoptosis. We investigated the effect of TLR3 ligand (poly(I:C)) in combination with chemotherapeutics applied to human pharyngeal carcinoma cells as a possible antitumor therapy.
    Methods: Human pharyngeal cancer cell lines were studied (FaDu and Detroit 562). Cytotoxicity assays and apoptosis assays (annexin V staining and caspase 3/7 activity measurements) were used to investigate the cytotoxic effects. By using TLR3 siRNA we confirmed that the observed effect is TLR3-dependent.
    Results: We found that the combined application of poly(I:C) and chemotherapeutics (cisPt, HU, 5-FU and MTX) has a stronger inhibitory effect on cell growth in tumor cells expressing functional TLR3 as compared with a single treatment. This is a result of TLR3-dependent apoptosis.
    Conclusion: Our study showed that a combined application of the two agents already being used in tumor therapy could lower the necessary dosage of chemotherapeutics, leading to fewer side effects.
    Mesh-Begriff(e) Antineoplastic Agents/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Dose-Response Relationship, Drug ; Humans ; Pharyngeal Neoplasms/drug therapy ; Pharyngeal Neoplasms/pathology ; Poly I-C/administration & dosage
    Chemische Substanzen Antineoplastic Agents ; Poly I-C (O84C90HH2L)
    Sprache Englisch
    Erscheinungsdatum 2011
    Erscheinungsland Switzerland
    Dokumenttyp Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 6708-8
    ISSN 1421-9794 ; 0009-3157
    ISSN (online) 1421-9794
    ISSN 0009-3157
    DOI 10.1159/000334122
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Immune thrombocytopenia: serum cytokine levels in children and adults.

    Culić, Srđana / Salamunić, Ilza / Konjevoda, Paško / Dajak, Slavica / Pavelić, Jasminka

    Medical science monitor : international medical journal of experimental and clinical research

    2013  Band 19, Seite(n) 797–801

    Abstract: Background: Immune thrombocytopenia (ITP) is an immune-mediated platelet disorder in which autoantibody-coated platelets are removed from the blood by monocytic phagocytes and there is impaired platelet production. There is a delicate balance of ... ...

    Abstract Background: Immune thrombocytopenia (ITP) is an immune-mediated platelet disorder in which autoantibody-coated platelets are removed from the blood by monocytic phagocytes and there is impaired platelet production. There is a delicate balance of specific cytokine levels, which has an important role in the immune system and is known to be deregulated in autoimmune diseases. This study was designed to investigate the differences in Th cytokine levels between children and adults with newly diagnosed ITP and to compare these profiles to those found in healthy, age-matched controls.
    Material/methods: The concentration of IL-1alpha, IL-2, IL-3, IL-4, IL-6, IL-10, TNF-alpha, IFN-alpha, and IFN-alpha in serum specimens was analyzed by enzyme-linked immunosorbent assay.
    Results: At the time of ITP diagnosis, children showed significantly lower serum levels of interleukin IL-2 and tumor necrosis factor TNF-alpha and higher serum level of IL-3 than healthy controls. Serum level of IL-4 in adult ITP patients was higher than those in control subjects. When compared with adults, children with ITP had lower serum level of IL-4, IL-6 and IFN-alpha, and higher level of IFN-alpha.
    Conclusions: Significant differences in serum cytokine levels between pediatric patients and healthy controls indicate that cytokine disturbances--especially changes in IL-2, IL-3 and TNF-alpha--might be involved in the pathogenesis of newly diagnosed ITP. TNF-alpha is the most informative variable for discrimination between healthy children and those with ITP.
    Mesh-Begriff(e) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Croatia ; Cytokines/blood ; Enzyme-Linked Immunosorbent Assay ; Humans ; Infant ; Interferons/blood ; Interleukins/blood ; Middle Aged ; Multivariate Analysis ; Platelet Count ; Purpura, Thrombocytopenic, Idiopathic/blood ; Tumor Necrosis Factor-alpha/blood
    Chemische Substanzen Cytokines ; Interleukins ; Tumor Necrosis Factor-alpha ; Interferons (9008-11-1)
    Sprache Englisch
    Erscheinungsdatum 2013-09-27
    Erscheinungsland United States
    Dokumenttyp Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1439041-3
    ISSN 1643-3750 ; 1234-1010
    ISSN (online) 1643-3750
    ISSN 1234-1010
    DOI 10.12659/MSM.884017
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Toll-like receptor 3 stimulation triggers metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF.

    Matijevic Glavan, Tanja / Cipak Gasparovic, Ana / Vérillaud, Benjamin / Busson, Pierre / Pavelic, Jasminka

    Molecular carcinogenesis

    2017  Band 56, Heft 4, Seite(n) 1214–1226

    Abstract: Toll-like receptor 3 (TLR3) has a dual role in cancer; its activation can trigger apoptosis as well as stimulate cancer cell survival, proliferation, and progression. We have shown here that TLR3 activation can induce metabolic reprogramming in a ... ...

    Abstract Toll-like receptor 3 (TLR3) has a dual role in cancer; its activation can trigger apoptosis as well as stimulate cancer cell survival, proliferation, and progression. We have shown here that TLR3 activation can induce metabolic reprogramming in a pharyngeal cancer cell line, leading to increased aerobic glycolysis, cell migration, elevated levels of reactive oxidative species (ROS), and decreased anti-oxidative response. Key proteins in these signaling pathways are heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), pyruvate kinase M2 (PKM2), and CD44 variants, which were over-expressed after TLR3 stimulation. TLR3 activation also induced upregulation of different genes involved in cancer progression (VEGF, MMP9, uPAR) and enzymes involved in glycolytic pathway. Most of the observed effects were Myc-dependent; however, some of them were also connected with MAPK and HIF signaling pathways. Since TLR3 agonists are being investigated as potential novel cancer therapy adjuvants and apoptosis inducers, alone or in combination with other therapeutic options, data presented here suggest extreme caution before their introduction into clinical practice. The fact that TLR3 ligands [poly(I:C) and poly(A:U)] can also aid cancer survival and progression, through induction of metabolic reprogramming, emphasizes the need to investigate this particular topic. Our data suggest that the combination of TLR3 ligands with Myc or MAPK inhibitors may be a way to neutralize their undesirable effects while enhancing their anti-tumor effect. © 2016 Wiley Periodicals, Inc.
    Mesh-Begriff(e) Cell Line, Tumor ; Cell Movement ; Glycolysis ; Humans ; Hypoxia-Inducible Factor 1/metabolism ; MAP Kinase Signaling System ; Oxidative Stress ; Pharyngeal Neoplasms/metabolism ; Pharyngeal Neoplasms/pathology ; Pharynx/metabolism ; Pharynx/pathology ; Poly I-C/metabolism ; Proto-Oncogene Proteins c-myc/metabolism ; Reactive Oxygen Species/metabolism ; Signal Transduction ; Toll-Like Receptor 3/metabolism
    Chemische Substanzen Hypoxia-Inducible Factor 1 ; Proto-Oncogene Proteins c-myc ; Reactive Oxygen Species ; TLR3 protein, human ; Toll-Like Receptor 3 ; Poly I-C (O84C90HH2L)
    Sprache Englisch
    Erscheinungsdatum 2017-04
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1004029-8
    ISSN 1098-2744 ; 0899-1987
    ISSN (online) 1098-2744
    ISSN 0899-1987
    DOI 10.1002/mc.22584
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang